Back to Results
First PageMeta Content
Antifibrinolytics / Aprotinin / Proteins / Food and Drug Administration / Bayer / Pharmaceutical sciences / Medicine / Clinical research


REPORT ON TRASYLOL® FOR
Add to Reading List

Document Date: 2007-08-16 12:12:20


Open Document

File Size: 219,16 KB

Share Result on Facebook

City

New York City / Washington / DC / Berlin / /

Company

Bayer Healthcare AG / BAYER CORPORATION AND BAYER AG / Ingenix / Epidemiology / Wiley Rein / Medical Science / Bayer Pharmaceuticals / ZUCKERMAN SPAEDER LLP / Global Regulatory Affairs / New England Journal / UnitedHealth Group / German AG / Global Clinical Development / U.S. Drug Safety Assurance / /

Continent

Europe / North America / /

Country

Germany / United States / /

Event

Person Communication and Meetings / Product Recall / Product Issues / FDA Phase / Conference Call / /

Facility

FDA headquarters / /

IndustryTerm

on-line edition / executive producer / law / /

MedicalCondition

coma / cardiovascular and renal disorders / renal dysfunction / stroke / pancreatitis / encephalopathy / myocardial infarction / heart failure / /

MedicalTreatment

Cardiac Surgery / surgery / bypass / dialysis / blood transfusion / /

Organization

BHC-AG / McGill University / Trasylol Steering Committee / FDA / BPC / Department of Integrated Analysis / Advisory Committee Steering Committee / Harvard / Food and Drug Administration’s Cardiovascular and Renal Drugs Advisory Committee / Trasylol Business Unit / White House / U.S. Food and Drug Administration / Renal Drugs Advisory Committee / Advisory Committee / /

Person

Samy Suissa / Paul MacCarthy / John Seeger / Kemal Malik / Alex Walker / Fred Fielding / Mike Rozycki / Alexander Walker / Anita Shah / Pam Cyrus / Perspective Comparative / Michael Rozycki / Stephen Zaruby / Max Wegner / Ulrike von Schmeling / Tomasz Dyszynski / Howard Dorfman / Trasylol / Ernst Weidmann / Drug Safety / Franz-Joseph Wingen / Andrea Nadel / Ed Tucker / Terry Taylor / Joseph Scheeren / Bush / David van Veenhuyzen / Kuno Sprenger / Allen Heller / /

Position

President / Vice President / Senior Vice President of 1 On October / Safety Manager / Vice President / Head / physician / Global Head of Development and Chief Medical Officer / Manager for Aprotinin / Head / Vice President / Global Clinical Development / Vice President for Trasylol / Vice President for GDS / Global Project Leader / Director of US Regulatory Affairs / CONTENTS EXECUTIVE / attorney / Counsel / C. D. E. F. EXECUTIVE / Premier / i3 representative / Deputy Director of Statistics / executive producer ” / Advisor for GDS / Risk Manager / Vice President / Global Head / Senior Vice President / Commissioner / Head of Patents / Senior Vice President of 1 On / Leader / /

Product

TRASYLOL / intention / aminocaproic acid / slide / tranexamic / /

ProvinceOrState

Maryland / /

PublishedMedium

the New England Journal of Medicine / /

Technology

dialysis / /

SocialTag